![Chemical structure of 5-methyl-8-(4-methylpiperazin-1-yl)-4-thia-2,9-diazatricyclo[8.4.0.0^{3,7}]tetradeca-1(10),3(7),5,8,11,13-hexaene, CAS 132539-06-1](https://api.angenesci.com/structure/693/132539-06-1.png)
无数据
无数据
无数据
| CAS Number | 132539-06-1 |
| Catalog Number | AG0010SF(AGN-PC-0PJR5G) |
| Chemical Name | 5-methyl-8-(4-methylpiperazin-1-yl)-4-thia-2,9-diazatricyclo[8.4.0.0^{3,7}]tetradeca-1(10),3(7),5,8,11,13-hexaene |
| IUPAC Name | 2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine |
| InChI | InChI=1S/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3 |
| InChI Key | KVWDHTXUZHCGIO-UHFFFAOYSA-N |
| MDL Number | MFCD00866702 |
| Molecular Formula | C17H20N4S |
| Molecular Weight | 312.4325 |
| SMILES | CC1=CC2=C(NC3=C(N=C2N2CCN(CC2)C)C=CC=C3)S1 |
| UNII | N7U69T4SZR |
| Synonyms | 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine,
LY 170052,
LY 170053,
LY-170052,
LY170052,
olanzapine,
olanzapine pamoate,
Zolafren,
Zyprexa,
olanzapine,
132539-06-1,
Zyprexa,
Zyprexa Zydis,
Olansek,
Zalasta,
Zyprexa Intramuscular,
Zyprexa Velotab,
olanzapinum,
LY-170053,
Zolafren,
Zypadhera,
Lanzac,
2-Methyl-4-(4-methylpiperazin-1-yl)-10H-benzo[b]thieno[2,3-e][1,4]diazepine,
LY 170053,
2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine,
Olzapin,
Oferta,
UNII-N7U69T4SZR,
2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine,
10H-thieno[2,3-b][1,5]benzodiazepine, 2-methyl-4-(4-methyl-1-piperazinyl)-,
CHEMBL715,
N7U69T4SZR,
2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine,
2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine,
CHEBI:7735,
C17H20N4S,
KVWDHTXUZHCGIO-UHFFFAOYSA-N,
MFCD00866702,
olanzapina,
NCGC00096077-03,
LY170053,
DSSTox_CID_3388,
DSSTox_RID_77010,
DSSTox_GSID_23388,
Midax,
Zydis,
Olanzapine [USAN:INN],
Olanzapine Mylan,
2-Methyl-4-(4-methyl-1-piperazinyl)- 10H-thieno[2,3-b][1,5]benzodiazepine,
2-methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[3,2-c][1,5]benzodiazepine,
Olanzapine Teva,
10H-Thieno(2,3-b)(1,5)benzodiazepine, 2-methyl-4-(4-methyl-1-piperazinyl)-,
5-methyl-8-(4-methylpiperazin-1-yl)-4-thia-2,9-diazatricyclo[8.4.0.0^{3,7}]tetradeca-1(10),3(7),5,8,11,13-hexaene,
Olanzapine (OLA),
SMR000466345,
Olanzapine Neopharma,
CAS-132539-06-1,
SR-01000759343,
Olanzapin,
Olanzapine (JAN/USAN/INN),
LY-170052,
ALKS-7921,
HSDB 8155,
Olanzapine [USAN:USP:INN:BAN],
Olanzapine(Zyprexa),
Olanzapine (Zyprexa),
KS-1090,
AC1L1IHS,
ACMC-209wx7,
GTPL47,
BIDD:PXR0138,
SCHEMBL28763,
US8802672, Olanzapine,
KSC177A9B,
MLS000759457,
MLS001165781,
MLS001195646,
MLS001424057,
BIDD:GT0332,
SCHEMBL117695,
SPECTRUM1505024,
Jsp001969,
DTXSID9023388,
Olanzapine, >=98% (HPLC),
BDBM35254,
BDBM82479,
CHEBI:94534,
CTK0H7090,
CTK6I2959,
KS-00000XJV,
HMS2051H05,
HMS2089M04,
HMS2093I04,
HMS2233F24,
HMS3374L02,
HMS3393H05,
HMS3657I15,
HMS3714J03,
ACT03231,
ALBB-027265,
BCP04917,
EBD23216,
NSC_4585,
ZINC3873830,
Tox21_111556,
AC-665,
ANW-46937,
CO0033,
s2493,
STK634338,
STL388024,
ZINC52957434,
2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[2,3-b][1,5]benzodiazepine,
AKOS000282888,
AKOS005566122,
Olanzapine 1.0 mg/ml in Acetonitrile,
Tox21_111556_1,
ACN-029909,
AN-6960,
BCP9001021,
CCG-100922,
CS-1114,
DB00334,
MCULE-1620364835,
NC00172,
NCGC00096077-01,
NCGC00096077-04,
NCGC00096077-05,
NCGC00096077-06,
NCGC00389791-02,
BC206213,
BR-57874,
CJ-20712,
CPD000466345,
HY-14541,
I960,
SAM001246652,
SC-16244,
SBI-0206786.P001,
AB0013948,
AB1008596,
AJ-112146,
LS-152313,
RT-003566,
ST2417070,
TL8000772,
CAS_132539-06-1,
FT-0612957,
O0393,
SW220248-1,
A10667,
C07322,
D00454,
J10363,
S-4287,
AB00639907-06,
AB00639907-07,
AB00639907_08,
AB00639907_09,
539O061,
A806453,
L000455,
L005958,
I06-0784,
J-006186,
SR-01000759343-4,
SR-01000759343-6,
Z1868057799,
Olanzapine, European Pharmacopoeia (EP) Reference Standard,
Olanzapine, United States Pharmacopeia (USP) Reference Standard,
Olanzapine, Pharmaceutical Secondary Standard; Certified Reference Material,
(E)-2-methyl-4-(4-methylpiperazin-1-yl)-10H-benzo[b]thieno[2,3-e][1,4]diazepine,
2-Methyl-10-(4-methyl-piperazin-1-yl)-4H-3-thia-4,9-diaza-benzo[f]azulene,
2-methyl-4-(4-methyl-1-piperazinyl)-10 H -thieno[2,3- b ] [1,5]benzodiazepine,
2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno-[2,3-b][1,5]benzodiazepine,
2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine #,
2-methyl-4-(4-methylpiperazin-1-yl)-5H-benzo[b]thieno[2,3-e][1,4]diazepine,
5h-thieno[2,3-b][1,5]benzodiazepine, 2-methyl-4-(4-methyl-1-piperazinyl)-,
Olanzapine for system suitability, European Pharmacopoeia (EP) Reference Standard,
Olanzapine-d8, 100 mug/mL in acetonitrile, ampule of 1 mL, certified reference material,
2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine; Lanzac; Zyprexa,
5-methyl-8-(4-methylpiperazin-1-yl)-4-thia-2,9-diazatricyclo[8.4.0.0(3),?]tetradeca-1(14),3(7),5,8,10,12-hexaene,
5-methyl-8-(4-methylpiperazin-1-yl)-4-thia-2,9-diazatricyclo[8.4.0.0(3),]tetradeca-1(14),3(7),5,8,10,12-hexaene,
5-methyl-8-(4-methylpiperazin-1-yl)-4-thia-2,9-diazatricyclo[8.4.0.0^{3,7}]tetradeca-1(10),2,5,7,11,13-hexaene,
Olanzapine solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material,
Symbyax,
Integrol,
Olazax,
Olanzapine pamoate,
Olanzapine Teva,
Olazax Disperzi,
Mixture Name,
Zyprexa Relprevv,
Zyprexa (TN),
olanzapine embonate,
Olanzapine Glenmark,
Zolafren (TN),
Olzapin (TN),
Rexapin (TN),
Zalasta (TN),
Zydis (TN),
Lilly brand of olanzapine,
Olanzapine Glenmark Europe,
D0V4QS,
Olanzapine pamoate monohydrate,
Eli Lilly brand of olanzapine,
CID4585,
C17-H20-N4-S,
CS-O-30992,
LY170052,
LY 170052,
B2240,
C076029,
D000077152,
10H-tieno [2,3-b] [1,5 benzodiazepina], 2-metil-4-(4-metil-1-piperacinil)-,
2-methyl-4-(4-methyl-1-piperazinyl)-10 H-thieno[2,3-b ] [1,5]benzodiazepine,
57-88-5,
Olanzapine, 99%, a high affinity for 5-HT2 serotonin and D2 dopamine receptor antagonist - 1g 1g,
|
| Complexity | 432 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 312.141g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 22 |
| Hydrogen Bond Acceptor Count | 4 |
| Hydrogen Bond Donor Count | 1 |
| Isotope Atom Count | 0 |
| Molecular Weight | 312.435g/mol |
| Monoisotopic Mass | 312.141g/mol |
| Rotatable Bond Count | 1 |
| Topological Polar Surface Area | 59.1A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 2.9 |
| Symbol: | |
| Hazard Class | 6.1 |
| Hazard statements | H225-H302+H312+H332-H319-H315-H413 |
| Packing Group | Ⅲ |
| Precautionary statements | P210-P261-P302+P352+P312-P304+P340+P312-P337+P313-P403+P235-P305+P351+P338 |
| UN Code | UN 2811 |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

